Regulatory Update The FDA has approved the first oral GLP-1 receptor agonist for weight management, marking a significant milestone in obesity treatment
Its a comprehensive gut microbiome test, rather than a guess
Encouragingly, the picture isn't fixed: at ENDO 2025, researchers reported that higher protein intake may help prevent muscle loss in these patients
FSA eligibility depends on the medication being prescribed by a doctor and intended to treat or manage a medical conditionin this case, weight management and metabolic health
Caffeine sensitive individuals may experience the following symptoms including, but not limited to, restlessness, nervousness, tremors, headache, anxiety, palpitations, increased heart rate, or difficulty sleeping